Griffith University. "Combating human parainfluenza virus." ScienceDaily. www.sciencedaily.com / releases / 2015 / 02 / 150211124037.htm (accessed April 19, 2025).

Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin–neuraminidase inhibitors. Nature Communications, 2014; 5: 5268 DOI: 10.1038/ncomms6268 ...

Researchers at Griffith University's Institute for Glycomics have moved a step closer to identifying a treatment for the dreaded Human parainfluenza virus (hPIV). These highly-infectious viruses ...

Publications: “Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys,” Lingemann M, Liu X, Surman ...

In experiments described in the journal Nature Communications, the team reports how they discovered two rare antibodies that, if combined into a “cocktail,” can block infection by all four of those ...

May 23, 2010 (Dallas, Texas) — An outbreak of human parainfluenza virus type 3 (hPIV-3) infection among recipients of hematopoietic stem cell transplants (HSCTs) in an outpatient clinic ...

PARAINFLUENZA Type 1 virus is an important cause of acute respiratory disease in infants and children.1 , 2 During primary infection the lower respiratory tract is often involved, and illness may b ...

Inoculation Of Human Volunteers With Parainfluenza Viruses Types 1 And 3 (Ha 2 And Ha 1) D. A. J. Tyrrell, M. L. Bynoe, K. Birkum Petersen, R. N. P. Sutton and Marguerite S. Pereira The British ...

The virus can be more severe in young children and in older adults, and the U.S. typically sees some 20,000 to 25,000 influenza deaths per year, though that number can reach as high as 60,000 ...